Cefdinir Api - Pharmaceutical Active Ingredient

Cefdinir API (CAS No. 91832‑40‑5) is a high‑purity third‑generation cephalosporin antibiotic Active Pharmaceutical Ingredient with broad‑spectrum antibacterial activity. It is widely used in regulated pharmaceutical formulations for the treatment of bacterial infections in adults, adolescents, and pediatric patients (≥ 6 months). Cefdinir works by inhibiting bacterial cell‑wall synthesis, leading to bacterial cell death. It is effective against a wide range of Gram‑positive and Gram‑negative organisms, while remaining ineffective against viral infections such as the common cold or influenza. Cefdinir is commonly incorporated into formulations for: Respiratory tract infections Acute bronchitis Community‑acquired pneumonia Sinusitis ENT infections Otitis media Pharyngitis Tonsillitis Skin and soft‑tissue infections Pediatric bacterial infections Its excellent oral bioavailability and safety profile make it especially suitable for pediatric dry syrups and oral suspensions. 🧪 Specifications & Details Product Name: Cefdinir Synonyms: Cefdinir Product Code: ATM167CEFD Grade: USP CAS Number: 91832‑40‑5 Molecular Formula: C14H13N5O5S2 Molecular Weight: 395.4 g/mol COA & MSDS: Available on request 📦 Packaging & Storage Packaging: 25 Kg HDPE drums with double liner bags inside (export‑worthy) Storage Condition: Store in air‑tight containers Protect from direct light and moisture ⭐ Key Features Manufactured in WHO‑GMP compliant facilities High‑purity third‑generation cephalosporin API Broad‑spectrum antibacterial activity Excellent stability and controlled impurity profile Suitable for oral solid and liquid dosage forms Ideal for pediatric and adult formulations Consistent batch‑to‑batch quality Export‑grade API with full documentation (COA, MSDS) 💊 Applications Used in regulated pharmaceutical formulations for: Oral tablets and capsules Pediatric dry syrups and suspensions ENT and respiratory infection therapies Skin and soft‑tissue infection treatments Broad‑spectrum oral antibiotic preparations Cefdinir API, Third Generation Cephalosporin Bulk Drug, Broad Spectrum Antibiotic API, Pediatric Antibiotic Ingredient, Respiratory Infection Treatment Raw Material, Active Pharmaceutical Ingredient, CAS 91832‑40‑5, USP Grade, WHO‑GMP Certified, Pharmaceutical Export. #Cefdinir #PharmaceuticalAPI #Cephalosporin #AntibioticAPI #BroadSpectrumAntibiotic #PediatricAntibiotic #BulkDrugs #ActiveIngredient #PharmaExport #CAS91832405 #USPGrade About the Company GST Registration Date: 2020 Legal Status of Firm: Proprietorship Number of Employees: 11 To 25 People Annual Turnover: 40 L - 1.5 Cr